143 related articles for article (PubMed ID: 21595537)
1. Fluocinolone acetonide implant (Retisert) for chronic cystoid macular edema in two patients with AIDS and a history of cytomegalovirus retinitis.
Hu J; Coassin M; Stewart JM
Ocul Immunol Inflamm; 2011 Jun; 19(3):206-9. PubMed ID: 21595537
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
Ufret-Vincenty RL; Singh RP; Lowder CY; Kaiser PK
Am J Ophthalmol; 2007 Feb; 143(2):334-5. PubMed ID: 17258523
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
[TBL] [Abstract][Full Text] [Related]
4. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
5. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
[TBL] [Abstract][Full Text] [Related]
6. Fluocinolone acetonide intravitreal implant (Retisert
Leinonen S; Immonen I; Kotaniemi K
Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
[TBL] [Abstract][Full Text] [Related]
7. Visual loss in cytomegalovirus retinitis caused by cystoid macular edema in patients without the acquired immune deficiency syndrome.
Maguire AM; Nichols CW; Crooks GW
Ophthalmology; 1996 Apr; 103(4):601-5. PubMed ID: 8618759
[TBL] [Abstract][Full Text] [Related]
8. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
Arevalo JF; Mendoza AJ; Ferretti Y
Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
10. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
Badelon I; Gohier P; Chaine G
J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
[TBL] [Abstract][Full Text] [Related]
11. Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.
Shen BY; Punjabi OS; Lowder CY; Sears JE; Singh RP
Retina; 2013 Apr; 33(4):873-7. PubMed ID: 23407350
[TBL] [Abstract][Full Text] [Related]
12. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis.
Park UC; Kim SJ; Yu HG
Ocul Immunol Inflamm; 2011 Aug; 19(4):282-3. PubMed ID: 21770807
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
Jain N; Stinnett SS; Jaffe GJ
Ophthalmology; 2012 Jan; 119(1):132-7. PubMed ID: 21924503
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants.
Freitas-Neto CA; Maghsoudlou A; Dhanireddy S; Payal A; Boonsopon S; Ratwatte MD; Foster CS
Ocul Immunol Inflamm; 2015; 23(6):425-9. PubMed ID: 25541739
[TBL] [Abstract][Full Text] [Related]
18. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
[TBL] [Abstract][Full Text] [Related]
19. Cystoid macular edema as a result of immune-recovery uveitis.
Guzak R; Rodman J; Pizzimenti J
Optom Vis Sci; 2011 Feb; 88(2):E344-51. PubMed ID: 21217412
[TBL] [Abstract][Full Text] [Related]
20. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
Retina; 2001; 21(1):1-9. PubMed ID: 11217922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]